{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:53:45Z","timestamp":1777632825336,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T00:00:00Z","timestamp":1504915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T00:00:00Z","timestamp":1504915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1017028"],"award-info":[{"award-number":["APP1017028"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1113867"],"award-info":[{"award-number":["APP1113867"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1082458"],"award-info":[{"award-number":["APP1082458"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT130101417"],"award-info":[{"award-number":["FT130101417"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"crossref","award":["F'ship"],"award-info":[{"award-number":["F'ship"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10549-017-4496-x","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T16:29:20Z","timestamp":1505147360000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Multidimensional phenotyping of breast cancer cell lines to guide preclinical research"],"prefix":"10.1007","volume":"167","author":[{"given":"Jodi M.","family":"Saunus","sequence":"first","affiliation":[]},{"given":"Chanel E.","family":"Smart","sequence":"additional","affiliation":[]},{"given":"Jamie R.","family":"Kutasovic","sequence":"additional","affiliation":[]},{"given":"Rebecca L.","family":"Johnston","sequence":"additional","affiliation":[]},{"given":"Priyakshi","family":"Kalita-de Croft","sequence":"additional","affiliation":[]},{"given":"Mariska","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"Esdy N.","family":"Rozali","sequence":"additional","affiliation":[]},{"given":"Ana Cristina","family":"Vargas","sequence":"additional","affiliation":[]},{"given":"Lynne E.","family":"Reid","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Lorsy","sequence":"additional","affiliation":[]},{"given":"Sibylle","family":"Cocciardi","sequence":"additional","affiliation":[]},{"given":"Tatjana","family":"Seidens","sequence":"additional","affiliation":[]},{"given":"Amy E.","family":"McCart Reed","sequence":"additional","affiliation":[]},{"given":"Andrew J.","family":"Dalley","sequence":"additional","affiliation":[]},{"given":"Leesa F.","family":"Wockner","sequence":"additional","affiliation":[]},{"given":"Julie","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Debina","family":"Sarkar","sequence":"additional","affiliation":[]},{"given":"Marjan E.","family":"Askarian-Amiri","sequence":"additional","affiliation":[]},{"given":"Peter T.","family":"Simpson","sequence":"additional","affiliation":[]},{"given":"Kum Kum","family":"Khanna","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[]},{"given":"Fares","family":"Al-Ejeh","sequence":"additional","affiliation":[]},{"given":"Sunil R.","family":"Lakhani","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,9,9]]},"reference":[{"issue":"1","key":"4496_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10549-009-0460-8","volume":"121","author":"A Hollestelle","year":"2009","unstructured":"Hollestelle A et al (2009) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat 121(1):53\u201364","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"4496_CR2","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/bcr2755","volume":"12","author":"PJ Keller","year":"2010","unstructured":"Keller PJ et al (2010) Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast cancer research: BCR 12(5):R87","journal-title":"Breast cancer research: BCR"},{"issue":"7","key":"4496_CR3","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD et al (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121(7):2750\u20132767","journal-title":"J Clin Invest"},{"issue":"6","key":"4496_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","volume":"10","author":"RM Neve","year":"2006","unstructured":"Neve RM et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515\u2013527","journal-title":"Cancer Cell"},{"issue":"5","key":"4496_CR5","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A et al (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast cancer research: BCR 12(5):R68","journal-title":"Breast cancer research: BCR"},{"issue":"6","key":"4496_CR6","doi-asserted-by":"publisher","first-page":"e64388","DOI":"10.1371\/journal.pone.0064388","volume":"8","author":"CE Smart","year":"2013","unstructured":"Smart CE et al (2013) In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS ONE 8(6):e64388","journal-title":"PLoS ONE"},{"issue":"7","key":"4496_CR7","doi-asserted-by":"publisher","first-page":"e6146","DOI":"10.1371\/journal.pone.0006146","volume":"4","author":"J Kao","year":"2009","unstructured":"Kao J et al (2009) Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery. PLoS ONE 4(7):e6146","journal-title":"PLoS ONE"},{"issue":"10","key":"4496_CR8","doi-asserted-by":"publisher","first-page":"R110","DOI":"10.1186\/gb-2013-14-10-r110","volume":"14","author":"A Daemen","year":"2013","unstructured":"Daemen A et al (2013) Modeling precision treatment of breast cancer. Genome Biol 14(10):R110","journal-title":"Genome Biol"},{"issue":"7391","key":"4496_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J et al (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603\u2013607","journal-title":"Nature"},{"issue":"6","key":"4496_CR10","doi-asserted-by":"publisher","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD et al (2016) Refinement of Triple-Negative Breast Cancer Molecular Subtypes: implications for Neoadjuvant Chemotherapy Selection. PLoS ONE 11(6):e0157368","journal-title":"PLoS ONE"},{"issue":"2","key":"4496_CR11","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/bcr1982","volume":"10","author":"CM Fillmore","year":"2008","unstructured":"Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10(2):R25","journal-title":"Breast Cancer Res"},{"issue":"2","key":"4496_CR12","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1186\/bcr2560","volume":"12","author":"E Lim","year":"2010","unstructured":"Lim E et al (2010) Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 12(2):R21","journal-title":"Breast Cancer Res"},{"key":"4496_CR13","doi-asserted-by":"crossref","unstructured":"McCart Reed, A.E., et al., The Brisbane Breast Bank. Open Journal of Bioresources, 2017. In Press","DOI":"10.5334\/ojb.33"},{"issue":"6","key":"4496_CR14","doi-asserted-by":"publisher","first-page":"e64388","DOI":"10.1371\/journal.pone.0064388","volume":"8","author":"CE Smart","year":"2013","unstructured":"Smart CE et al (2013) In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS ONE 8(6):e64388","journal-title":"PLoS ONE"},{"issue":"4","key":"4496_CR15","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/bcr2603","volume":"12","author":"L Da Silva","year":"2010","unstructured":"Da Silva L et al (2010) HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Res 12(4):R46","journal-title":"Breast Cancer Res"},{"key":"4496_CR16","unstructured":"International Agency for Research on Cancer (IARC). TP53 database. Available from: \n                    http:\/\/www-p53.iarc.fr\/"},{"issue":"9","key":"4496_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L et al (2016) TP53 Variations in Human Cancers: new Lessons from the IARC TP53 database and genomics data. Hum Mutat 37(9):865\u2013876","journal-title":"Hum Mutat"},{"key":"4496_CR18","unstructured":"COSMIC, the Catalogue Of Somatic Mutations In Cancer. Cell lines project; Available from: \n                    http:\/\/cancer.sanger.ac.uk\/cancergenome\/projects\/cell_lines\/"},{"key":"4496_CR19","unstructured":"The Broad Institute. Cancer Cell Line Encyclopedia. Available from: \n                    http:\/\/www.broadinstitute.org\/ccle\/home"},{"key":"4496_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2407-3-13","volume":"3","author":"M Nugoli","year":"2003","unstructured":"Nugoli M et al (2003) Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications. BMC Cancer 3:13","journal-title":"BMC Cancer"},{"issue":"13","key":"4496_CR21","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1158\/0008-5472.CAN-09-1528","volume":"69","author":"AF Chambers","year":"2009","unstructured":"Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69(13):5292\u20135293","journal-title":"Cancer Res"},{"issue":"19","key":"4496_CR22","doi-asserted-by":"publisher","first-page":"7893","DOI":"10.1158\/0008-5472.CAN-09-2396","volume":"69","author":"A Hollestelle","year":"2009","unstructured":"Hollestelle A, Schutte M (2009) Comment Re: mDA-MB-435 and M14 cell lines: identical but not M14 Melanoma? Cancer Res 69(19):7893","journal-title":"Cancer Res"},{"issue":"4","key":"4496_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3892\/ol.2013.1157","volume":"5","author":"AG Nerlich","year":"2013","unstructured":"Nerlich AG, Bachmeier BE (2013) Density-dependent lineage instability of MDA-MB-435 breast cancer cells. Oncol Lett 5(4):1370\u20131374","journal-title":"Oncol Lett"},{"issue":"1","key":"4496_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-006-9392-8","volume":"104","author":"JM Rae","year":"2007","unstructured":"Rae JM et al (2007) MDA-MB-435 cells are derived from M14 melanoma cells\u2013a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104(1):13\u201319","journal-title":"Breast Cancer Res Treat"},{"key":"4496_CR25","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/npjbcancer.2015.2","volume":"1","author":"VV Prasad","year":"2015","unstructured":"Prasad VV, Gopalan RO (2015) Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014. NPJ Breast Cancer 1:15002","journal-title":"NPJ Breast Cancer"},{"key":"4496_CR26","unstructured":"R Core Team. R: A language and environment for statistical computing. 2014; Available from: \n                    http:\/\/www.r-project.org\/"},{"issue":"1","key":"4496_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13058-016-0681-9","volume":"18","author":"RL Johnston","year":"2016","unstructured":"Johnston RL et al (2016) High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations. Breast Cancer Res 18(1):18","journal-title":"Breast Cancer Res"},{"issue":"4","key":"4496_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1530\/ERC-12-0065","volume":"19","author":"NL Moore","year":"2012","unstructured":"Moore NL et al (2012) An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocr Relat Cancer 19(4):599\u2013613","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"4496_CR29","first-page":"3923","volume":"6","author":"J Alsner","year":"2000","unstructured":"Alsner J et al (2000) Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin Cancer Res 6(10):3923\u20133931","journal-title":"Clin Cancer Res"},{"key":"4496_CR30","unstructured":"TCGA, Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature, 2012. 490(7418): p. 61-70"},{"issue":"4","key":"4496_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M Kobel","year":"2016","unstructured":"Kobel M et al (2016) Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res 2(4):247\u2013258","journal-title":"J Pathol Clin Res"},{"key":"4496_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/nar\/gkq929","volume":"39","author":"SA Forbes","year":"2011","unstructured":"Forbes, SA et al (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39:945\u2013950","journal-title":"Nucleic Acids Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4496-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:02:30Z","timestamp":1589720550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4496-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4496"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4496-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,9]]},"assertion":[{"value":"23 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}